Retia Medical
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
* | N/A | Spinout | |
* | $7.0m | Series A | |
* | $15.0m | Series B | |
Total Funding | €20.0m |
Recent News about Retia Medical
EditRetia Medical specializes in advancing cardiac output (CO) monitoring to enhance patient care. The company's flagship product, the Argos CO Monitor, is designed for critical care teams, providing a more accurate, easy-to-use, and affordable hemodynamic monitor. The Argos CO Monitor features an intuitive user interface and an easy-to-read display, enabling quick interpretation of hemodynamic data. It seamlessly connects to vital signs monitors and is designed to integrate with Electronic Medical Records (EMR) systems, providing immediate access to hemodynamics. Retia Medical operates in the healthcare market, specifically targeting hospitals and critical care units. The business model revolves around selling the Argos CO Monitor, which eliminates disposable costs by pulling data directly from vital signs monitors. This cost-effective approach supports confident, data-driven decisions, ultimately improving patient care and safety.
Keywords: cardiac output monitoring, critical care, hemodynamic data, Argos CO Monitor, intuitive interface, seamless connectivity, EMR integration, cost-effective, patient care, healthcare market.